Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives
2017; Nature Portfolio; Volume: 13; Issue: 12 Linguagem: Inglês
10.1038/nrneurol.2017.144
ISSN1759-4766
AutoresLidia Yshii, Reinhard Hohlfeld, Roland Liblau,
Tópico(s)Cancer Immunotherapy and Biomarkers
Referência(s)